SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Prospector who wrote (2619)7/6/1998 12:44:00 PM
From: Jim B  Read Replies (2) of 5402
 
1) is the company going to get an IR firm in place
2) what is the company doing to grow market awareness about SGNC as
an investment (obviously tomorrow's meeting is a big step.. but what else)
3) What is the most immediate goal that SGNC plans on attaining.
4) What is if any.. the current cash on hand and liabilities?? (If this hasn't already been answered -- I may have missed it)
5) See if you can get an update on patents.. anything new going to be filed?
6) Is SGNC currently in any talks with other major R&D firms and how
are they going? Is the interest in SGNC an investment one or technology acquisition/partnership one?
7) Does SGNC plan on updating the investing public monthly with status on testing via press releases?? Every 2 months??? What can we
expect on this?

Can't think of anything else right now.

jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext